Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,074
Closed -$646K 128
2025
Q1
$646K Buy
2,074
+20
+1% +$5.91K 0.49% 65
2024
Q4
$535K Buy
2,054
+440
+27% +$131K 0.39% 80
2024
Q3
$520K Buy
+1,614
New +$528K 0.38% 83

Other funds holding AMGN

Prossimo Advisors's AMGN Position: Q2 2025 in Review

Prossimo Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 2,074 shares — an estimated $646K sold.

Prossimo Advisors first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $646K in Q1 2025. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Prossimo Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Prossimo Advisors sold 2,074 Amgen shares in Q2 2025, an estimated $646K.
  • Prossimo Advisors first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
  • Prossimo Advisors's Amgen position peaked at $646K in Q1 2025.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Prossimo Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.